TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Sanofi-Aventis Norge AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
751,239
|
689,984
|
734,621 |
Financial expenses |
1,304
|
1,309
|
1,013 |
Earnings before taxes |
41,999
|
59,552
|
29,085 |
Total assets |
351,862
|
398,813
|
326,202 |
Current assets |
349,308
|
396,264
|
323,110 |
Current liabilities |
346,589
|
347,867
|
171,928 |
Equity capital |
5,273
|
50,946
|
154,274 |
- share capital |
1,820
![]() |
1,820
![]() |
1,820 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.5%
|
12.8%
|
47.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
5.6%
|
8.6%
|
4.0% |
Return on assets (ROA) |
12.3%
|
15.3%
|
9.2% |
Current ratio |
100.8%
|
113.9%
|
187.9% |
Return on equity (ROE) |
796.5%
|
116.9%
|
18.9% |
Change turnover |
61,255
|
-44,637
|
40,359 |
Change turnover % |
9%
|
-6%
|
6% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.